# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the la...
S&P 500 and Nasdaq 100 indices gain for seventh straight day, marking best weekly performance since October 2023 on positiv...
The "Mad Money" host says Dexcom had "a real bad miss... they still really haven't fully explained why that is....
Baird analyst Jeff Johnson maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $80 to $82.
Baird analyst Jeff Johnson downgrades DexCom (NASDAQ:DXCM) from Outperform to Neutral and lowers the price target from $161 ...
Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, ...